GGrantIndex
← Leaderboards

Joseph C Liao

Veterans Admin Palo Alto Health Care Sys

$11,013,084
Attributed
$17,626,716
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,626,716 · 7
VA$0 · 2

By mechanism

R01$12,208,450 · 4
U01$3,680,144 · 1
K12$1,303,310 · 1
R21$434,812 · 1
I01$0 · 2

Top collaborators

Others in their field

Top investigators on “Diagnostic

Research focus

DiagnosticDiagnosisTechnologyMolecularDetectionRecurrenceUrineMalignant NeoplasmsMalignant Neoplasm Of Urinary BladderTumorCystoscopyUrinaryScientistValidationOperative Surgical ProceduresProspectiveHigh RiskCancer DetectionRisk StratificationTransurethral ResectionFoundationsDiagnostic SensitivityCancer PatientCessation Of Life

Grant awards (37)

Multidisciplinary K12 Urologic Research at Stanford (KUReS) Career Development Program$434,161
K12 · FY2025 · DK · contact PI
Intraoperative integration of artificial intelligence during cystoscopic surgery$234,937
R01 · FY2025 · CA · contact PI
Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers$0
I01 · FY2025 · VA · contact PI
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Leveraging Artificial Neural Networks to Enhance Detection of Carcinoma in situ$0
I01 · FY2025 · VA · contact PI
Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer$559,757
R01 · FY2024 · CA
Intraoperative integration of artificial intelligence during cystoscopic surgery$530,360
R01 · FY2024 · CA · contact PI
Multidisciplinary K12 Urologic Research at Stanford (KUReS) Career Development Program$434,440
K12 · FY2024 · DK · contact PI
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Leveraging Artificial Neural Networks to Enhance Detection of Carcinoma in situ$0
I01 · FY2024 · VA · contact PI
Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers$0
I01 · FY2024 · VA · contact PI
Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer$585,127
R01 · FY2023 · CA
Intraoperative integration of artificial intelligence during cystoscopic surgery$496,091
R01 · FY2023 · CA · contact PI
Multidisciplinary K12 Urologic Research at Stanford (KUReS) Career Development Program$434,709
K12 · FY2023 · DK · contact PI
Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers$0
I01 · FY2023 · VA · contact PI
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Leveraging Artificial Neural Networks to Enhance Detection of Carcinoma in situ$0
I01 · FY2023 · VA · contact PI
Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer$595,388
R01 · FY2022 · CA
Intraoperative integration of artificial intelligence during cystoscopic surgery$514,044
R01 · FY2022 · CA · contact PI
MagSToNE - a magnetic system for kidney stone fragment elimination$238,062
R21 · FY2022 · DK · contact PI
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Leveraging Artificial Neural Networks to Enhance Detection of Carcinoma in situ$0
I01 · FY2022 · VA · contact PI
Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers$0
I01 · FY2022 · VA · contact PI
Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer$618,012
R01 · FY2021 · CA
MagSToNE - a magnetic system for kidney stone fragment elimination$196,750
R21 · FY2021 · DK · contact PI
Personalized assessment of bladder cancer treatment response using urinary molecular biomarkers$0
I01 · FY2021 · VA · contact PI
Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer$625,866
R01 · FY2020 · CA
A Droplet-based single cell platform for pathogen identification and AST$972,239
R01 · FY2019 · AI
A Droplet-based single cell platform for pathogen identification and AST$1,152,798
R01 · FY2018 · AI
A Droplet-based single cell platform for pathogen identification and AST$1,168,562
R01 · FY2017 · AI
A Droplet-based single cell platform for pathogen identification and AST$1,184,852
R01 · FY2016 · AI
A Droplet-based single cell platform for pathogen identification and AST$1,256,392
R01 · FY2015 · AI
Optical Imaging of Bladder Cancer with Molecular Contrast Agents$415,127
R01 · FY2014 · CA · contact PI
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification$638,971
U01 · FY2013 · AI · contact PI
Optical Imaging of Bladder Cancer with Molecular Contrast Agents$412,251
R01 · FY2013 · CA · contact PI
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification$684,752
U01 · FY2012 · AI · contact PI
Optical Imaging of Bladder Cancer with Molecular Contrast Agents$434,155
R01 · FY2012 · CA · contact PI
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification$869,349
U01 · FY2011 · AI · contact PI
Optical Imaging of Bladder Cancer with Molecular Contrast Agents$452,492
R01 · FY2011 · CA · contact PI
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification$730,719
U01 · FY2010 · AI · contact PI
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification$756,353
U01 · FY2009 · AI · contact PI